Physicochemical and Biological Evaluation of Curdlan-Poly(Lactic-Co-Glycolic Acid) Nanoparticles as a Host-Directed Therapy Against Mycobacterium Tuberculosis.

"Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health under Award Number K43TW010371 granted to AD and 5R01AI152109 from the National Institute of Allergy and Infectious Diseases (NIAID) awarded to SLS and AD. SLS is funded by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF) of South Africa, award number UID 86539. The authors acknowledge the SA MRC Centre for TB Research and DST/NRF Centre of Excellence for Biomedical Tuberculosis Research for financial support for this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the SA MRC or the NRF."